5R.S. Legro, Diagnostic criteria in polycystic ovary syndrome, Semin Report Med 2003, 21: 267-275.
6Kalro BN, Laucks TJ,Berqa SL. Neuromodulation in polycysfic ovary syndrome[J]. Obstet Gynecol Clin North Am, 2001, 28(1): 35-62.
7De Leo VDE, Marca ALA. Petiaglia F. Insulin-lowering agents in the management of polycystic ovary syndrome[J]. Endocrine REV, 2003, 24(5): 633-667.
8Colak R, Kelestimur F, Unluhizarti K, et al. A comparison between the ffects of low dose (1 microg )and standard dose(250 microg)hCTH stimulation tests on adrenal P450C17 alpha enzyme activity in women with polycystic ovary syndrome[J]. Eur Endocrinol, 2002, 147(4): 473-477.
9Pasquali R, Gambineri A. Insulin-sensitizing agents in polycystic ovary syndrome[J]. Eur J Endocrinol, 2006, 154(6): 763-775.
10Veldhuis JD, Pincus SM, Garcia--Rudaz MC, et al. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome[J]. J Clin Endocrinol Metab, 2001, 86 (8): 3772-3778.
